Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Among authors: zhou x. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
Winer EP, Lipatov O, Im SA, Goncalves A, Muñoz-Couselo E, Lee KS, Schmid P, Tamura K, Testa L, Witzel I, Ohtani S, Turner N, Zambelli S, Harbeck N, Andre F, Dent R, Zhou X, Karantza V, Mejia J, Cortes J; KEYNOTE-119 investigators. Winer EP, et al. Among authors: zhou x. Lancet Oncol. 2021 Apr;22(4):499-511. doi: 10.1016/S1470-2045(20)30754-3. Epub 2021 Mar 4. Lancet Oncol. 2021. PMID: 33676601 Clinical Trial.
Pembrolizumab in Triple-Negative Breast Cancer. Reply.
Cortes J, Zhou X, Schmid P. Cortes J, et al. Among authors: zhou x. N Engl J Med. 2022 Oct 13;387(15):1436. doi: 10.1056/NEJMc2210919. N Engl J Med. 2022. PMID: 36239658 No abstract available.
[Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
Wang KL, Mei YY, Cui L, Gao C, Liu FF, Zhao XX, Li WJ, Jiang J, Zhang RD, Xie J, Shi HW, Wang B, Zhang YH, Ma XL, Wu MY, Zhou X, Li ZG. Wang KL, et al. Among authors: zhou x. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):285-90. doi: 10.7534/j.issn.1009-2137.2014.02.005. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 24762993 Chinese.
Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission.
Qi HZ, Xu J, Yang QQ, Lin R, Wang ZX, Zhao K, Wang Q, Zhou X, Fan ZP, Huang F, Xu N, Xuan L, Jin H, Sun J, Gale RP, Zhou HS, Liu QF. Qi HZ, et al. Among authors: zhou x, zhou hs. Bone Marrow Transplant. 2022 Nov;57(11):1704-1711. doi: 10.1038/s41409-022-01796-2. Epub 2022 Aug 30. Bone Marrow Transplant. 2022. PMID: 36042299
Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
Zhou X, Tu S, Wang C, Huang R, Deng L, Song C, Yue C, He Y, Yang J, Liang Z, Wu A, Li M, Zhou W, Du J, Guo Z, Li Y, Jiao C, Liu Y, Chang LJ, Li Y. Zhou X, et al. Among authors: zhou w. Front Immunol. 2020 Nov 27;11:564099. doi: 10.3389/fimmu.2020.564099. eCollection 2020. Front Immunol. 2020. PMID: 33329526 Free PMC article. Clinical Trial.
48,882 results
You have reached the last available page of results. Please see the User Guide for more information.